Abstract
Basal-cell carcinomas (BCCs) are the most common cancer in Caucasians. It has been reported that the patched gene is inactivated in 30 – 40% sporadic BCCs and 20% sporadic medulloblastomas via loss of heterozygosity and nonsense mutations. Recently, two activating smoothened mutations have been found in the sporadic basal cell carcinomas. One, at base pair 1604 (G-to-T transversion) of exon 9, changes codon 535 from tryptophan to leucine, and the other, at base pair 1685 (G-to-A transition) of exon 10, changes codon 562 from arginine to glutamine (Xie et al., 1998). In our study, 1604G→T was found in 20 out of 97 (20.6%) sporadic BCCs. The high prevalence indicates that 1604G is the mutation hot spot in our tumor samples. This mutation was detected in all three histological subtypes of BCCs, suggesting that smoothened mutation is an early event during the development of the tumor. Our finding of a high smoothened mutation rate, together with high frequent patched gene mutations reported recently, indicates that activation of the hedgehog signal transduction pathway is the most common and early event in the development of sporadic BCCs. Additionally, to determine whether smoothened, like patched, is also involved in the carcinogenesis of medulloblastomas, we screened medulloblastoma samples for these two mutations by restriction analysis. We have found the 1604G→T mutation in 1 out of 21 medulloblastomas. This result confirmed smoothened gene involvement in the carcinogenesis of medulloblastoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ and Ponten J. . 1991 Proc. Natl. Acad. Sci. USA 88: 10124–10128.
Dahmane N, Lee J, Robins P, Heller P and Ruiz i Altaba A. . 1997 Nature 389: 876–881.
Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE and Toftgard R. . 1996 Nat. Genet. 14: 78–81.
Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B and Bale AE. . 1996 Cell 85: 841–851.
Hutchinson F. . 1994 Mutat. Res. 309: 11–15.
Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein Jr EH and Scott MP. . 1996 Science 272: 1668–1671.
Lahiri DK and Nurnberger Jr JL. . 1991 Nucleic Acids Res. 19: 5444.
Mak AS, Poon AM, Leung CY, Kwan KH, Wong TT and Tung MK. . 1995 Scand. J. Plast. Reconstr. Surg. Hand. Surg. 29: 149–152.
Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW and James CD. . 1997 Cancer Res. 57: 842–845.
Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S. . 1997 Proc. Natl. Acad. Sci. USA 94: 808–813.
Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, Scott MP, Pennica D, Goddard A, Phillips H, Noll M, Hooper JE, de Sauvage F and Rosenthal A. . 1996 Nature 384: 129–134.
Wicking C, Shanley S, Smyth I, Gillies S, Negus K, Graham S, Suthers G, Haites N, Edwards M, Wainwright B and Chenevix-Trench G. . 1997 Am. J. Hum. Genet. 60: 21–26.
Wong SS, Tan KC and Goh CL. . 1998 J. Am. Acad. Dermatol. 38: 179–185.
Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein Jr EH and de Sauvage FJ. . 1998 Nature 391: 90–92.
Acknowledgements
We thank CH Ma for performing the sequence analysis and Veronica Chua for proofreading the manuscript. This work was supported by The Chinese University of Hong Kong Direct Grant (project code 2040660) and Concern Foundation (9350 Civic Center Drive, Suite 103, Beverly Hills, CA 90210, USA).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lam, CW., Xie, J., To, KF. et al. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18, 833–836 (1999). https://doi.org/10.1038/sj.onc.1202360
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202360
Keywords
This article is cited by
-
Novel animal model of soft tissue tumor due to aberrant hedgehog signaling activation in pericyte lineage
Cell and Tissue Research (2022)
-
Clinical Implications of Primary Cilia in Skin Cancer
Dermatology and Therapy (2020)
-
A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma
Oncogene (2017)
-
Genetic landscape of meningioma
Brain Tumor Pathology (2016)
-
Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy
Tumor Biology (2015)